These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8165902)

  • 1. Developmental change in activity of red cell porphobilinogen deaminase and its electrophoretic variant in the Japanese population.
    Namba H; Narahara K; Tsuji K; Yokoyama Y; Murakami M; Matsubara T; Seino Y
    Acta Paediatr Jpn; 1994 Feb; 36(1):16-9. PubMed ID: 8165902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation and evaluation of two porphobilinogen deaminase activity assays for diagnosis of acute intermittent porphyria.
    Lin CN; Huang YC; Ro LS; Liao MF; Ning HC; Kuo HC
    Clin Chim Acta; 2018 Apr; 479():1-6. PubMed ID: 29317194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porphobilinogen deaminase gene mutations in Polish patients with non-erythroid acute intermittent porphyria.
    Szlendak U; Lipniacka A; Bianketti J; Podolak-Dawidziak M; Bykowska K
    Adv Clin Exp Med; 2015; 24(1):63-8. PubMed ID: 25923088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haem precursors and porphobilinogen deaminase in erythrocytes and lymphocytes of patients with acute intermittent porphyria.
    Gross U; Jacob K; Frank M; Doss MO
    Cell Mol Biol (Noisy-le-grand); 1997 Feb; 43(1):29-35. PubMed ID: 9074786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porphobilinogen deaminase over-expression in hepatocytes, but not in erythrocytes, prevents accumulation of toxic porphyrin precursors in a mouse model of acute intermittent porphyria.
    Unzu C; Sampedro A; Mauleón I; Vanrell L; Dubrot J; de Salamanca RE; González-Aseguinolaza G; Melero I; Prieto J; Fontanellas A
    J Hepatol; 2010 Mar; 52(3):417-24. PubMed ID: 19815305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of porphobilinogen deaminase activity in human erythrocytes: pertinent factors in obtaining optimal conditions for measurements.
    Erlandsen EJ; Jørgensen PE; Markussen S; Brock A
    Scand J Clin Lab Invest; 2000 Nov; 60(7):627-34. PubMed ID: 11202055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of low erythrocyte porphobilinogen deaminase activity in Finland.
    Mustajoki P; Kauppinen R; Lannfelt L; Lilius L; Koistinen J
    J Intern Med; 1992 Apr; 231(4):389-95. PubMed ID: 1588264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mutation in the porphobilinogen deaminase gene in an extended Chinese family with acute intermittent porphyria.
    Yang J; Wang H; Yin K; Hua B; Zhu T; Zhao Y; Guo S; Yu X; Wu W; Zhou Z
    Gene; 2015 Jul; 565(2):288-90. PubMed ID: 25870942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of age and gender on the clinical expression of acute intermittent porphyria based on molecular study of porphobilinogen deaminase gene among Swiss patients.
    Schuurmans MM; Schneider-Yin X; Rüfenacht UB; Schnyder C; Minder CE; Puy H; Deybach JC; Minder EI
    Mol Med; 2001 Aug; 7(8):535-42. PubMed ID: 11591889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte porphobilinogen deaminase activity in porphyria cutanea tarda.
    Siersema PD; de Rooij FW; Edixhoven-Bosdijk A; Wilson JH
    Clin Chem; 1990 Oct; 36(10):1779-83. PubMed ID: 2208654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assignment of human porphobilinogen deaminase to 11q24.1----q24.2 by in situ hybridization and gene dosage studies.
    Namba H; Narahara K; Tsuji K; Yokoyama Y; Seino Y
    Cytogenet Cell Genet; 1991; 57(2-3):105-8. PubMed ID: 1914516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exon 1 donor splice site mutations in the porphobilinogen deaminase gene in the non-erythroid variant form of acute intermittent porphyria.
    Puy H; Gross U; Deybach JC; Robréau AM; Frank M; Nordmann Y; Doss M
    Hum Genet; 1998 Nov; 103(5):570-5. PubMed ID: 9860299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte porphobilinogen deaminase activity and primary liver cancer.
    Kaczynski J; Hansson G; Thunell S; Wetterberg L; Wallerstedt S
    J Intern Med; 1995 Mar; 237(3):309-13. PubMed ID: 7891052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute intermittent porphyria: prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France.
    Nordmann Y; Puy H; Da Silva V; Simonin S; Robreau AM; Bonaiti C; Phung LN; Deybach JC
    J Intern Med; 1997 Sep; 242(3):213-7. PubMed ID: 9350165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute intermittent porphyria: expression of mutant and wild-type porphobilinogen deaminase in COS-1 cells.
    Mustajoki S; Laine M; Lahtela M; Mustajoki P; Peltonen L; Kauppinen R
    Mol Med; 2000 Aug; 6(8):670-9. PubMed ID: 11055586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and biochemical studies of acute intermittent porphyria in 196 patients and their families.
    Kauppinen R; von und zu Fraunberg M
    Clin Chem; 2002 Nov; 48(11):1891-900. PubMed ID: 12406973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Three single nucleotide polymorphisms of porphobilinogen deaminase gene related to a Chinese patient with acute intermittent porphyria].
    Cao XP; Su L; Xiao HP; Liu YY; Li YB; Xiu LL
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(34):2414-6. PubMed ID: 19087719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute intermittent porphyria in two patients on anticonvulsant therapy and with normal erythrocyte porphobilinogen deaminase activity.
    Herrick AL; McColl KE; Moore MR; Brodie MJ; Adamson AR; Goldberg A
    Br J Clin Pharmacol; 1989 Apr; 27(4):491-7. PubMed ID: 2497768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased activity of porphobilinogen deaminase in erythrocytes during attacks of acute intermittent porphyria.
    Kostrzewska E; Gregor A
    Ann Clin Res; 1986; 18(4):195-8. PubMed ID: 3789651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of acute intermittent porphyria: a subtype with normal erythrocyte porphobilinogen deaminase activity in Germany.
    Gross U; Honcamp M; Doss MO
    Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):613-8. PubMed ID: 8877336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.